{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:43:27Z","timestamp":1773657807304,"version":"3.50.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.pharmthera.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T14:28:35Z","timestamp":1172154515000},"page":"171-183","source":"Crossref","is-referenced-by-count":42,"title":["Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application"],"prefix":"10.1016","volume":"114","author":[{"given":"M\u00e1rcia Renata","family":"Mortari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Olimpio Siqueira","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luzitano Brand\u00e3o","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2007.01.009_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1113\/jphysiol.1983.sp014714","article-title":"Effects of a spider toxin on the glutamatergic synapse of lobster muscle","volume":"339","author":"Abe","year":"1983","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib2","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/S0968-0896(01)00148-1","article-title":"Synthesis of novel GABA uptake inhibitors: Part 6. Preparation and evaluation of N-omega asymmetrically substituted nipecotic acid derivatives","volume":"9","author":"Andersen","year":"2001","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1022393604014","article-title":"Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate","volume":"28","author":"\u00c4ngehagen","year":"2003","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2220\/biomedres.8.241","article-title":"Chemical structure of joro spider toxin (JSTX)","volume":"8","author":"Aramaki","year":"1987","journal-title":"Biomed Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1389203054065437","article-title":"Conotoxins as research tools and drug leads","volume":"6","author":"Armishaw","year":"2005","journal-title":"Curr Protein Pept Sci"},{"issue":"S6","key":"10.1016\/j.pharmthera.2007.01.009_bib6","first-page":"39","article-title":"Anticonvulsant profile of conantokin-G: a novel, broad-spectrum NMDA antagonist","volume":"39","author":"Armstrong","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00019052-199810000-00008","article-title":"Ion channel mutations affecting muscle and brain","volume":"11","author":"Barchi","year":"1998","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.12.010","article-title":"The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression","volume":"59","author":"Barton","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2003.12.011","article-title":"The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs","volume":"59","author":"Barton","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.03.049","article-title":"Spider and wasp neurotoxins: pharmacological and biochemical aspects","volume":"493","author":"Beleboni","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10571-004-6913-z","article-title":"Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships","volume":"24","author":"Beleboni","year":"2004","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.01.009_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1124\/mol.105.017319","article-title":"Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine","volume":"69","author":"Beleboni","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0733-8619(02)00017-8","article-title":"New antiepileptic drug therapies","volume":"20","author":"Bergin","year":"2002","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-1211(02)00106-7","article-title":"Progress report on new antiepileptic drugs: a summary of the sixth Eilat conference (EILAT VI)","volume":"51","author":"Bialer","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2004.04.007","article-title":"Behavioral effects of the novel AMPA\/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain","volume":"47","author":"Blackburn-Munro","year":"2004","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1042\/bst0220888","article-title":"Polyamines and polyamine amides from wasps and spiders","volume":"22","author":"Blagbrough","year":"1994","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib17","first-page":"57","article-title":"New drugs for persons with epilepsy","volume":"76","author":"Blum","year":"1998","journal-title":"Adv Neurol"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/0929867013372319","article-title":"The inhibitory neural circuitry as target of antiepileptic drugs","volume":"8","author":"B\u00f6hme","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib19","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1460-9568.1997.tb01371.x","article-title":"Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: up-regulation in reorganized epileptogenic hippocampus","volume":"9","author":"Brines","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1076\/phbi.40.6.472.8436","article-title":"Anticonvulsant and GABA uptake inhibition properties of P. bistriata and S. raptoria spider venom fractions","volume":"40","author":"Cairr\u00e3o","year":"2002","journal-title":"Pharm Biol"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(03)00532-5","article-title":"Synaptic plasticity in the ischaemic brain","volume":"2","author":"Calabresi","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0091-3057(97)00407-3","article-title":"Behavioral, electroencephalographic, and histopathologic effects of a neuropeptide isolated from Tityus serrulatus scorpion venom in rats","volume":"60","author":"Carvalho","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1096\/fj.05-5545fje","article-title":"Allosteric interactions between scorpion toxin receptor sites on voltage-gated Na channels imply a novel role for weakly active components in arthropod venom","volume":"20","author":"Cohen","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0041-0101(92)90056-B","article-title":"Precursor structure of omega-conotoxin GVIA determined from a cDNA clone","volume":"30","author":"Colledge","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1570-9639(03)00155-9","article-title":"A novel class of peptide found in scorpion venom with neurodepressant effects in peripheral and central nervous system of the rat","volume":"1649","author":"Corona","year":"2003","journal-title":"Biochim Bioohys Acta"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2005.05.004","article-title":"Anticonvulsant effects of the wasp Polybia ignobilis venom on chemically induced seizures and action on GABA and glutamate receptors","volume":"141","author":"Cunha","year":"2005","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.01.009_bib28","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-1211(92)90030-W","article-title":"Chemical models of epilepsy with some reference to their aplicability in the development of aniconvulsants","volume":"12","author":"De Deyn","year":"1992","journal-title":"Epilepsy Res"},{"issue":"2--3","key":"10.1016\/j.pharmthera.2007.01.009_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0041-0101(00)00129-X","article-title":"Purification and amino acid sequence of a highly insecticidal toxin from the venom of the brazilian spider Phoneutria nigriventer which inhibits NMDA-evoked currents in rat hippocampal neurones","volume":"39","author":"de Figueiredo","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib116","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(96)90074-4","article-title":"Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy","volume":"347","author":"de Silva","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib30","first-page":"1","article-title":"Mechanisms of action of new antiepileptic drugs","volume":"76","author":"Dichter","year":"1998","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0006-8993(89)90249-7","article-title":"Uptake of gamma-aminobutyric acid and l-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparation","volume":"490","author":"Dodd","year":"1989","journal-title":"Brain Res"},{"issue":"13","key":"10.1016\/j.pharmthera.2007.01.009_bib32","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1073\/pnas.85.13.4910","article-title":"Structure and synthesis of a potent glutamate receptor antagonist in wasp venom","volume":"85","author":"Eldefrawi","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib34","series-title":"A Catalogue of Nomenclature and Taxonomy in the Living, Conidae 1758\u20131998","author":"Filmer","year":"2001"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1984.tb09689.x","article-title":"Glutamate: a neurotransmitter in mammalian brain","volume":"42","author":"Fonnum","year":"1984","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.01.009_bib36","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.bjp.0705352","article-title":"Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake","volume":"139","author":"Fontana","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.01.009_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.lfs.2006.10.002","article-title":"Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats","volume":"80","author":"Gelfuso","year":"2007","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(96)00042-X","article-title":"Polyamine amides are neuroprotective in cerebellar granulle cell cultures challenged with excitatory amino acids","volume":"717","author":"Green","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib39","first-page":"1121","article-title":"Structure-functional characterization of argiopine- an ion channel blocker from the venom of spider Argiope lobata","volume":"12","author":"Grishin","year":"1986","journal-title":"Bioorg Khim"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(06)68182-8","article-title":"Epilepsy in children","volume":"367","author":"Guerrini","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01257076","article-title":"Spider toxin (JSTX-3) inhibits the convulsions induced by glutamate agonists","volume":"80","author":"Himi","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.01.009_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.toxicon.2005.01.020","article-title":"Three structurally related, highly potent, peptides from the venom of Parabuthus transvaalicus possess divergent biological activity","volume":"45","author":"Inceoglu","year":"2005","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.01.009_bib43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bcp.2004.06.039","article-title":"GABA pharmacology-what prospects for the future?","volume":"68","author":"Iversen","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(90)91243-A","article-title":"Anticonvulsivant action of an arylamine-containing fraction from Agelenopsis spider venom","volume":"526","author":"Jackson","year":"1990","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02246415","article-title":"Behavioural and anticonvulsant effects of Ca++ channel toxins in DBA\/2 mice","volume":"126","author":"Jackson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib45","first-page":"278","article-title":"Spider toxins as tools for dissecting elements of excitatory amino acid transmission","volume":"11","author":"Jackson","year":"1988","journal-title":"Tins"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.01.009_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1528-1157.1997.tb01205.x","article-title":"Epilepsy in developing countries","volume":"38","author":"Jallon","year":"1997","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.01.009_bib48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0041-0101(96)00065-7","article-title":"Two neurotoxins (BmK I and BmK II) from the venom of the scorpion Buthus martensi Karsch: purification, amino acid sequences and assessment of specific activity","volume":"34","author":"Ji","year":"1996","journal-title":"Toxicon"},{"issue":"1--2","key":"10.1016\/j.pharmthera.2007.01.009_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-1211(02)00101-8","article-title":"Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency","volume":"51","author":"Jimenez","year":"2002","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.01.009_bib52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/1381612003399653","article-title":"Conotoxins\u2014new vistas for peptide therapeutics","volume":"6","author":"Jones","year":"2000","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(91)90706-V","article-title":"Comparison of some arthropod toxins and toxin fragments as antagonists of excitatory amino acid-induced excitation of rat spinal neurones","volume":"204","author":"Jones","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1476-5381.1990.tb14189.x","article-title":"Philanthotoxin blocks quisqualate-, AMPA- and kainate-, but not NMDA-, induced excitation of rat brainstem neurones in vivo","volume":"101","author":"Jones","year":"1990","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(92)90357-F","article-title":"An analogue of Joro spider toxin selectively suppresses hippocampal epileptic discharges induced by quisqualate","volume":"581","author":"Kanai","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib54","first-page":"357","article-title":"Philanthotoxin inhibits Ca++-currents in rat hippocampal CA1 neurones","volume":"270","author":"Karst","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib57","series-title":"Natural and Synthetic Neurotoxins","first-page":"319","article-title":"Neurotoxins from spider venoms","author":"Kawai","year":"1993"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(82)91044-7","article-title":"Spider venom contains specific receptor blocker of glutaminergic synapses","volume":"247","author":"Kawai","year":"1982","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0041-0101(83)90101-0","article-title":"Specific antagonism of the glutamate receptor by an extract from the venom of the spider Araneus ventricosus","volume":"21","author":"Kawai","year":"1983","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(99)00649-7","article-title":"Inhibition of MK801 binding in adult rat brain sections by conantokin-G and conantokin-T","volume":"273","author":"Klein","year":"1999","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2174\/0929867013372328","article-title":"The NMDA receptor complex: a promising target for novel antiepileptic strategies","volume":"8","author":"Kohl","year":"2001","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00122-X","article-title":"The mechanisms of action of commonly used antiepileptic drugs","volume":"90","author":"Kwan","year":"2001","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib62","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.291.5.615","article-title":"The new antiepileptic drugs: clinical applications","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2006.09.052","article-title":"Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae)","volume":"1124","author":"Liberato","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01514-8","article-title":"New visions in the pharmacology of anticonvulsion","volume":"342","author":"L\u00f6scher","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2007.01.009_bib67","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb05996.x","article-title":"Antiepileptic drug mechanisms of action","volume":"36","author":"MacDonald","year":"1995","journal-title":"Epilepsia"},{"issue":"1--2","key":"10.1016\/j.pharmthera.2007.01.009_bib65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0006-8993(99)01472-9","article-title":"PhTx4, a new class of toxins from Phoneutria nigriventer spider venom, inhibits the glutamate uptake in rat brain synaptosomes","volume":"831","author":"Mafra","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib66","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/BF00979674","article-title":"Neurotoxic acylpolyamines from spider venoms","volume":"19","author":"McCormick","year":"1993","journal-title":"J Chem Ecol"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.01.009_bib69","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0041-0101(01)00145-3","article-title":"Cone venom\u2014from accidental stings to deliberate injection","volume":"39","author":"McIntosh","year":"2001","journal-title":"Toxicon"},{"issue":"23","key":"10.1016\/j.pharmthera.2007.01.009_bib68","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.1016\/S0021-9258(17)42601-9","article-title":"Gamma-carboxyglutamate in a neuroactive toxin","volume":"259","author":"McIntosh","year":"1984","journal-title":"J Biol Chem"},{"issue":"11 Suppl 8","key":"10.1016\/j.pharmthera.2007.01.009_bib70","first-page":"S14","article-title":"The role of glutamate in epilepsy and other CNS disorders","volume":"44","author":"Meldrum","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib71","first-page":"67","article-title":"Action of established and novel anticonvulsant drugs on the basic mechanisms of epilepsy","volume":"11","author":"Meldrum","year":"1996","journal-title":"Epilepsy Res"},{"issue":"Suppl. 9","key":"10.1016\/j.pharmthera.2007.01.009_bib72","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1997.tb05204.x","article-title":"Identification and preclinical testing of novel antiepileptic compounds","volume":"38","author":"Meldrum","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-6147(90)90184-A","article-title":"Excitatory amino acid neurotoxicity and neurodegenerative disease","volume":"11","author":"Meldrum","year":"1990","journal-title":"Trends Pharmacol Sci"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2007.01.009_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(99)00051-0","article-title":"Glutamate receptors and transporters in genetic and acquired models of epilepsy","volume":"36","author":"Meldrum","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.toxicon.2004.02.003","article-title":"Targeting ionotropic receptors with polyamine-containing toxins","volume":"43","author":"Mellor","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib75","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0028-3908(02)00336-2","article-title":"Modification of the philanthotoxin-343 polyamine moiety results in different structure-activity profiles at muscle nicotinic ACh, NMDA and AMPA receptors","volume":"44","author":"Mellor","year":"2003","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib77","first-page":"6","article-title":"Venom peptides as human pharmaceuticals","volume":"4","author":"Miljanich","year":"1997","journal-title":"Sci Med"},{"issue":"6363","key":"10.1016\/j.pharmthera.2007.01.009_bib78","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/355827a0","article-title":"P-type calcium channels blocked by the spider toxin omega-Aga-IVA","volume":"355","author":"Mintz","year":"1992","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.pharmthera.2007.01.009_bib79","doi-asserted-by":"crossref","first-page":"15986","DOI":"10.1021\/bi0511181","article-title":"A novel conotoxin framework with a helix-loop-helix (Cs alpha\/alpha) fold","volume":"44","author":"Moller","year":"2005","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib80","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-7843.2005.pto_137.x","article-title":"Anticonvulsant and behavioural effects of the denatured venom of the social wasp Polybia occidentalis (Polistinae, Vespidae)","volume":"97","author":"Mortari","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib81","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1749-6632.1999.tb08023.x","article-title":"NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies","volume":"890","author":"Mueller","year":"1999","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s007260070047","article-title":"NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience","volume":"19","author":"Mueller","year":"2000","journal-title":"Amino Acids"},{"issue":"2--3","key":"10.1016\/j.pharmthera.2007.01.009_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2004.08.064","article-title":"A anticonvulsive fraction from Scaptocosa raptoria (Araneae: Lycosidae) spider venom","volume":"371","author":"Mussi-Ribeiro","year":"2004","journal-title":"Neurosci Lett"},{"issue":"6994","key":"10.1016\/j.pharmthera.2007.01.009_bib84","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/429798a","article-title":"Venomous snails: one slip, and you're dead\u2026","volume":"429","author":"Nelson","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib85","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(02)01025-0","article-title":"A microdialysis study of glutamate concentration in the hippocampus of rats after TsTX toxin injection and blockade of toxin effects by glutamate receptor antagonists","volume":"74","author":"Nencioni","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0960-894X(01)00733-8","article-title":"An efficient and versatile synthesis of acylpolyamine spider toxins","volume":"12","author":"Nihei","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.01.009_bib87","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.toxicon.2006.07.022","article-title":"Conotoxins down under","volume":"48","author":"Norton","year":"2006","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib90","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1091\/mbc.8.11.2101","article-title":"Conus venom peptides, receptor and ion channel targets, and drug design: 50\u00a0million years of neuropharmacology","volume":"8","author":"Olivera","year":"1997","journal-title":"Mol Biol Cell"},{"issue":"4732","key":"10.1016\/j.pharmthera.2007.01.009_bib88","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.4071055","article-title":"Peptide neurotoxins from fish-hunting cone snails","volume":"230","author":"Olivera","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib89","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.bi.63.070194.004135","article-title":"Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins","volume":"63","author":"Olivera","year":"1994","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.01.009_bib91","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0959-4388(99)00033-1","article-title":"Effects of Conus peptides on the behavior of mice","volume":"9","author":"Olivera","year":"1999","journal-title":"Curr Opin Neurobiol"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.01.009_bib92","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.toxicon.2003.10.009","article-title":"PnTx4-3, a new insect toxin from Phoneutria nigriventer venom elicits the glutamate uptake inhibition exhibited by PhTx4 toxic fraction","volume":"42","author":"Oliveira","year":"2003","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib93","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2004.10.027","article-title":"Effects of microinjections of neurotoxin AvTx8, isolated from the social wasp Agelaia vicina (Hymenoptera; Vespidae) venom, on GABAergic nigrotectal pathways","volume":"1031","author":"Oliveira","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib94","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib95","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1528-1157.1997.tb01728.x","article-title":"GABA and epileptogenesis","volume":"38","author":"Olsen","year":"1997","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib96","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.eye.6701588","article-title":"Optic nerve and neuroprotection strategies","volume":"18","author":"Osborne","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib97","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0306-4492(82)90098-3","article-title":"6-Philanthotoxin, a semi-irreversible blocker of ion channels","volume":"72","author":"Piek","year":"1982","journal-title":"Comp Biochem Physiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib143","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.neuint.2006.04.009","article-title":"Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer","volume":"49","author":"Pinheiro","year":"2006","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib99","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1099-0461(2000)14:2<88::AID-JBT4>3.0.CO;2-G","article-title":"Effects of the crude venom of the social wasp Agelaia vicina on g-aminobutyric acid and glutamate uptake in synaptosomes from rat cerebral cortex","volume":"14","author":"Pizzo","year":"2000","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jbt.20014","article-title":"Characterization of the actions of AvTx7 isolated from Agelaia vicina (Hymenoptera: Vespidae) wasp venom on synaptosomal glutamate uptake and release","volume":"18","author":"Pizzo","year":"2004","journal-title":"J Biochem Mol Toxicol"},{"issue":"Suppl 1 Pt A","key":"10.1016\/j.pharmthera.2007.01.009_bib101","doi-asserted-by":"crossref","first-page":"697A","DOI":"10.1097\/00002826-199201001-00360","article-title":"Theoretical and practical considerations concerning the use of NMDA antagonists in the treatment of the epilepsies","volume":"15","author":"Porter","year":"1992","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1432-1327.1999.00625.x","article-title":"Scorpion toxins specific for Na+-channels","volume":"264","author":"Possani","year":"1999","journal-title":"Eur J Biochem"},{"issue":"9--10","key":"10.1016\/j.pharmthera.2007.01.009_bib103","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0300-9084(00)01167-6","article-title":"Peptides and genes coding for scorpion toxins that affect ion-channels","volume":"82","author":"Possani","year":"2000","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/bj3140145","article-title":"A novel tool for the investigation of glutamate release from rat cerebrocortical synaptosomes: the toxin Tx3-3 from the venom of the spider Phoneutria nigriventer","volume":"314","author":"Prado","year":"1996","journal-title":"Biochem J"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.01.009_bib106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/brain\/awf001","article-title":"Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy","volume":"125","author":"Proper","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0041-0101(01)00199-4","article-title":"Pharmacology and biochemistry of spider venoms","volume":"40","author":"Rash","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-8741(01)00327-0","article-title":"Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum","volume":"78","author":"Raza","year":"2001","journal-title":"J Ethonopharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib109","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/0264-6021:3430413","article-title":"Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin 3\u20134) from the spider Phoneutria nigriventer","volume":"343","author":"Reis","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib110","first-page":"325","article-title":"Scorpion toxins: chemistry and mode of action","volume":"3","author":"Rochat","year":"1979","journal-title":"Adv Cytopharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","article-title":"Diverse mechanisms of antiepileptic drugs in the development pipeline","volume":"69","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib142","first-page":"947","article-title":"AMPA receptors in epilepsy and as targets for antiepileptic drugs","volume":"79","author":"Rogawski","year":"1999","journal-title":"Adv Neurol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1134\/S106816200601002X","article-title":"Polymethyleneamine alkaloids of animal origin: II. Polyamine neurotoxins","volume":"32","author":"Rogoza","year":"2006","journal-title":"Russ J Bioorgan Chem"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.01.009_bib113","first-page":"904","article-title":"TsTx toxin isolated from Tityus serrulatus scorpion venom-induced spontaneous recurrent seizures and mossy fiber sprouting","volume":"43","author":"Sandoval","year":"2003","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001090000077","article-title":"Molecular mechanisms of calcium-dependent excitotoxicity","volume":"78","author":"Sattler","year":"2000","journal-title":"J Mol Med"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1359-6446(99)01454-3","article-title":"Conopeptides: from deadly venoms to novel therapeutics","volume":"5","author":"Shen","year":"2000","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4492(82)90029-6","article-title":"Partial purification of components from the paralysing venom of the digger wasp Philanthus triangulum and their action on neuromuscular transmission in the locust","volume":"71","author":"Spanjer","year":"1982","journal-title":"Comp Biochem Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.01.009_bib119","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1528-1157.1997.tb01477.x","article-title":"Voltage-activated calcium channels: targets of antiepileptic drug therapy?","volume":"38","author":"Stefani","year":"1997","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/tcr.20048","article-title":"Natural products as tools for studies of ligand-gated ion channels","volume":"5","author":"Stromgaard","year":"2005","journal-title":"Chem Rec"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib121","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/med.20004","article-title":"AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins","volume":"24","author":"Stromgaard","year":"2004","journal-title":"Med Res Rev"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib123","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1389557013406738","article-title":"Recent advances in the medicinal chemistry of polyamine toxins","volume":"1","author":"Stromgaard","year":"2001","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.01.009_bib122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.toxicon.2004.11.013","article-title":"Polyamine toxins: development of selective ligands for ionotropic receptors","volume":"45","author":"Stromgaard","year":"2005","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(95)01334-2","article-title":"Potent and long-lasting anticonvulsant effects of 1-naphthylacetyl spermine, an analogue of Joro spider toxin, against amygdaloid kindled seizures in rats","volume":"706","author":"Takazawa","year":"1996","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib125","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1006\/bbrc.2002.6570","article-title":"Modulation of sodium current in mammalian cells by an epilepsy-correlated beta 1-subunit mutation","volume":"291","author":"Tammaro","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.01.009_bib126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ppul.20299","article-title":"Role of N-methyl-d-aspartate receptor in hyperoxia-induced lung injury","volume":"40","author":"Tang","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1152\/physrev.00020.2003","article-title":"Conus venoms: a rich source of novel ion channel-targeted peptides","volume":"84","author":"Terlau","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib128","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0306-3623(96)00062-6","article-title":"Basis of the antiseizure action of phenytoin","volume":"27","author":"Tunnicliff","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0041-0101(96)00210-3","article-title":"Toxins affecting calcium channels in neurons","volume":"35","author":"Uchitel","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(91)90012-B","article-title":"Spider toxins affecting glutamate receptors: polyamines in therapeutic neurochemistry","volume":"52","author":"Usherwood","year":"1991","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-8749.1995.tb11978.x","article-title":"A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The paeditric EPITEG collaborative group","volume":"37","author":"Verity","year":"1995","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib132","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0028-3908(01)00026-0","article-title":"Preclinical avaliation of CHF3381 as a novel antiepileptic agent","volume":"40","author":"Villetti","year":"2001","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2007.01.009_bib134","first-page":"713","article-title":"Conus peptides\u2014a rich pharmaceutical treasure","volume":"36","author":"Wang","year":"2004","journal-title":"Acta Biochim Biophys"},{"key":"10.1016\/j.pharmthera.2007.01.009_bib133","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1046\/j.1432-1327.2001.02132.x","article-title":"Molecular characterization of an anti-epilepsy peptide from the scorpion Buthus martensi Karsch","volume":"268","author":"Wang","year":"2001","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/0300-5127:0280297","article-title":"l-Glutamate as a central neurotransmitter: looking back","volume":"28","author":"Watkins","year":"2000","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib136","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0022-3565(24)35308-X","article-title":"In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus","volume":"292","author":"White","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.01.009_bib137","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0028-3908(01)00112-5","article-title":"Point mutations identify the glutamate binding pocket of the N-methyl-d-aspartate receptor as major site of conantokin-G inhibition","volume":"41","author":"Wittekindt","year":"2001","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.01.009_bib138","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/j.1460-2075.1990.tb08204.x","article-title":"Constant and hypervariable regions in conotoxin propeptides","volume":"9","author":"Woodward","year":"1990","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.01.009_bib139","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0041-0101(98)00253-0","article-title":"Molecular characterization of a new excitatory insect neurotoxin with an analgesic effect on mice from the scorpion Buthus martensi Karsch","volume":"37","author":"Xiong","year":"1999","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.01.009_bib140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/jpet.103.058495","article-title":"Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats","volume":"308","author":"Yamashita","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.01.009_bib141","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj2570509","article-title":"Purification and N-terminal partial sequence of anti-epilepsy peptide from venom of the scorpion Buthus martensii Karsch","volume":"257","author":"Zhou","year":"1989","journal-title":"Biochem J"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:58:45Z","timestamp":1736816325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725807000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0163725807000228"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2007.01.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}